Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-TTK Polyclonal Antibody

Catalog #:   PHE04101 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: P33981
Overview

Catalog No.

PHE04101

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Human TTK (Gly532-Ala787).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000

Target

Dual specificity protein kinase TTK,MPS1L1,Phosphotyrosine picked threonine-protein kinase,TTK,PYT,MPS1

Purification

Purified by antigen affinity column.

Accession

P33981

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • Western Blot
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with TTK antibody (PHE04101) at 1 μg/ml.

    Lane 1: Recombinant protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 32 kDa
    Observed MW: 32 kDa
References

Optimized Biotinylated Peptide Detection Method for Characterizing the Cell Surface Proteome., PMID:40304900

D-- phenotype in a South Indian family: A multicentric approach to workup and management., PMID:40177882

Integrative analysis of serum proteomics and transcriptomics in hepatitis C., PMID:40082995

Kinetic, thermodynamic, and ab initio insights of AsnGly isomerisation as a ticking time bomb for protein integrity., PMID:39702829

In vitro and in vivo evaluation of Bombesin-MMAE conjugates for targeted tumour therapy., PMID:39146832

Rhnull phenotype in an Indian patient due to a novel c.1138 + 2 t > a mutation in the RHAG gene., PMID:38711255

Immunoglobulin-like transcript 2 as an impaired anti-tumor cytotoxicity marker of natural killer cells in patients with hepatocellular carcinoma., PMID:38638429

Differential anti-viral response to respiratory syncytial virus A in preterm and term infants., PMID:38447274

Experience from an immunohematology reference testing center., PMID:38274952

Effective synthesis, development and application of a highly fluorescent cyanine dye for antibody conjugation and microscopy imaging., PMID:37917021

Genomic Mapping of Epidermal Growth Factor Receptor and Mesenchymal-Epithelial Transition-Up-Regulated Tumors Identifies Novel Therapeutic Opportunities., PMID:37370859

A multicenter prospective observational study on the use of type and screen method versus conventional type and crossmatch policy for pre-transfusion testing in the Indian population., PMID:36190198

Overview on the role of complement-specific autoantibodies in diseases., PMID:36084516

Synthesis and characterization of new fluorescent boro-β-carboline dyes., PMID:35423835

Host cell targeting of novel antimycobacterial 4-aminosalicylic acid derivatives with tuftsin carrier peptides., PMID:35378278

Transcriptomic Mapping of Non-Small Cell Lung Cancer K-RAS p.G12C Mutated Tumors: Identification of Surfaceome Targets and Immunologic Correlates., PMID:35178045

RBD-specific antibody responses after two doses of BBIBP-CorV (Sinopharm, Beijing CNBG) vaccine., PMID:35073866

Modelling hypersensitivity to trastuzumab defines biomarkers of response in HER2 positive breast cancer., PMID:34620206

Tetraspanin 6 is a regulator of carcinogenesis in colorectal cancer., PMID:34521767

GSK137, a potent small-molecule BCL6 inhibitor with in vivo activity, suppresses antibody responses in mice., PMID:34274316

New aspects in the regulation of human B cell functions by complement receptors CR1, CR2, CR3 and CR4., PMID:34186155

Transcriptomic Profiles of CD47 in Breast Tumors Predict Outcome and Are Associated with Immune Activation., PMID:33917174

Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysis., PMID:33239067

Genomic and transcriptional changes in IFNγ pathway genes are putative biomarkers of response to ipilimumab immunotherapy in melanoma patients., PMID:33151785

Genomic Mapping Identifies Mutations in RYR2 and AHNAK as Associated with Favorable Outcome in Basal-Like Breast Tumors Expressing PD1/PD-L1., PMID:32796628

An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors., PMID:32753546

Proteomic identification of Placental Protein 1 (PP1), PP8, and PP22 and characterization of their placental expression in healthy pregnancies and in preeclampsia., PMID:32747003

Cysteine specific bioconjugation with benzyl isothiocyanates., PMID:35497170

Deciphering a delayed hemolytic transfusion reactions nightmare - Case of Chido/Roger antibodies., PMID:31896921

Detection and phenotyping of extracellular vesicles by size exclusion chromatography coupled with on-line fluorescence detection., PMID:31882862

Evidence for the Oocyte Mosaicism Selection model on the origin of Patau syndrome (trisomy 13)., PMID:31464342

Inflammatory signal induced IL-10 production of marginal zone B-cells depends on CREB., PMID:31216428

Complement component 1q subcomponent binding protein in the brain of the rat., PMID:30872665

Increased placental expression of Placental Protein 5 (PP5) / Tissue Factor Pathway Inhibitor-2 (TFPI-2) in women with preeclampsia and HELLP syndrome: Relevance to impaired trophoblast invasion?, PMID:30803712

Nuclear factor erythroid 2-related factors 1 and 2 are able to define the worst prognosis group among high-risk diffuse large B cell lymphomas treated with R-CHOEP., PMID:30755497

Adding to platelet safety and life: Platelet additive solutions., PMID:30692798

A Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR Therapy., PMID:30261609

Inhibin Is a Novel Paracrine Factor for Tumor Angiogenesis and Metastasis., PMID:29535220

Affinity Purification and Comparative Biosensor Analysis of Citrulline-Peptide-Specific Antibodies in Rheumatoid Arthritis., PMID:29361749

Functional studies of chronic lymphocytic leukemia B cells expressing β2-integrin type complement receptors CR3 and CR4., PMID:28577901

BCL6 represses antiviral resistance in follicular T helper cells., PMID:28550121

Regulatory B cells in rheumatoid arthritis: Alterations in patients receiving anti-TNF therapy., PMID:28506920

Characterisation of CCT271850, a selective, oral and potent MPS1 inhibitor, used to directly measure in vivo MPS1 inhibition vs therapeutic efficacy., PMID:28334731

Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer., PMID:28270606

Comparison of 5 Ki-67 antibodies regarding reproducibility and capacity to predict prognosis in breast cancer: does the antibody matter?, PMID:28188752

Gene expression profiling of anti-CTLA4-treated metastatic melanoma in patients with treatment-induced autoimmunity., PMID:27918555

In depth evaluation of the prognostic and predictive utility of PTEN immunohistochemistry in colorectal carcinomas: performance of three antibodies with emphasis on intracellular and intratumoral heterogeneity., PMID:27392434

MZ B cells migrate in a T-bet dependent manner and might contribute to the remission of collagen-induced arthritis by the secretion of IL-10., PMID:27343199

Comparison of Predictive Immunohistochemical Marker Expression of Primary Breast Cancer and Paired Distant Metastasis using Surgical Material: A Practice-Based Study., PMID:27029768

Ectopic transgene expression in the retina of four transgenic mouse lines., PMID:26563404

Datasheet

Document Download

Anti-TTK Polyclonal Antibody.pdf

 

$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-TTK Polyclonal Antibody [PHE04101]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only